These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 31195804)

  • 41. Aneurysmal subarachnoid hemorrhage in patients with migraine and tension headache: A cohort comparison study.
    Lamsam L; Bhambhvani HP; Thomas A; Ratliff JK; Moore JM
    J Clin Neurosci; 2020 Sep; 79():90-94. PubMed ID: 33070926
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long-term treatment patterns of prophylactic and acute migraine medications and incidence of opioid-related adverse events in patients with migraine.
    Bonafede M; Wilson K; Xue F
    Cephalalgia; 2019 Aug; 39(9):1086-1098. PubMed ID: 30818974
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cardiovascular and Cerebrovascular Events Are Associated With Nontraumatic Osteonecrosis of the Femoral Head.
    Sung PH; Yang YH; Chiang HJ; Chiang JY; Chen CJ; Yip HK; Lee MS
    Clin Orthop Relat Res; 2018 Apr; 476(4):865-874. PubMed ID: 29480889
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Migraine and subsequent risk of stroke in the Physicians' Health Study.
    Buring JE; Hebert P; Romero J; Kittross A; Cook N; Manson J; Peto R; Hennekens C
    Arch Neurol; 1995 Feb; 52(2):129-34. PubMed ID: 7848119
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Topiramate for migraine prophylaxis.
    Drug Ther Bull; 2006 Aug; 44(8):62-4. PubMed ID: 16903488
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Zonisamide versus topiramate in migraine prophylaxis: a double-blind randomized clinical trial.
    Mohammadianinejad SE; Abbasi V; Sajedi SA; Majdinasab N; Abdollahi F; Hajmanouchehri R; Faraji A
    Clin Neuropharmacol; 2011; 34(4):174-7. PubMed ID: 21738025
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Adherence to oral migraine-preventive medications among patients with chronic migraine.
    Hepp Z; Dodick DW; Varon SF; Gillard P; Hansen RN; Devine EB
    Cephalalgia; 2015 May; 35(6):478-88. PubMed ID: 25164920
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Efficacy of Multi-Modal Migraine Prophylaxis Therapy on Hyperacusis Patients.
    Abouzari M; Tan D; Sarna B; Ghavami Y; Goshtasbi K; Parker EM; Lin HW; Djalilian HR
    Ann Otol Rhinol Laryngol; 2020 May; 129(5):421-427. PubMed ID: 31786960
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antidepressants in long-term migraine prevention.
    Koch HJ; Jürgens TP
    Drugs; 2009; 69(1):1-19. PubMed ID: 19192933
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effective prophylactic treatments of migraine lower plasma glutamate levels.
    Ferrari A; Spaccapelo L; Pinetti D; Tacchi R; Bertolini A
    Cephalalgia; 2009 Apr; 29(4):423-9. PubMed ID: 19170689
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Utilization of topiramate during pregnancy and risk of birth defects.
    Green MW; Seeger JD; Peterson C; Bhattacharyya A
    Headache; 2012; 52(7):1070-84. PubMed ID: 22724387
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Low-dose topiramate versus lamotrigine in migraine prophylaxis (the Lotolamp study).
    Gupta P; Singh S; Goyal V; Shukla G; Behari M
    Headache; 2007 Mar; 47(3):402-12. PubMed ID: 17371357
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Is 6 months of migraine prophylaxis adequate?
    Bhoi SK; Kalita J; Misra UK
    Neurol Res; 2013 Dec; 35(10):1009-14. PubMed ID: 23890081
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Adherence with migraine prophylaxis in clinical practice.
    Berger A; Bloudek LM; Varon SF; Oster G
    Pain Pract; 2012 Sep; 12(7):541-9. PubMed ID: 22300068
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Unveiling the relative efficacy, safety and tolerability of prophylactic medications for migraine: pairwise and network-meta analysis.
    He A; Song D; Zhang L; Li C
    J Headache Pain; 2017 Dec; 18(1):26. PubMed ID: 28220376
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Drug safety and tolerability in prophylactic migraine treatment.
    Vécsei L; Majláth Z; Szok D; Csáti A; Tajti J
    Expert Opin Drug Saf; 2015 May; 14(5):667-81. PubMed ID: 25676133
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Topiramate for migraine prevention: a randomized controlled trial.
    Brandes JL; Saper JR; Diamond M; Couch JR; Lewis DW; Schmitt J; Neto W; Schwabe S; Jacobs D;
    JAMA; 2004 Feb; 291(8):965-73. PubMed ID: 14982912
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Topiramate versus amitriptyline in migraine prevention: a 26-week, multicenter, randomized, double-blind, double-dummy, parallel-group noninferiority trial in adult migraineurs.
    Dodick DW; Freitag F; Banks J; Saper J; Xiang J; Rupnow M; Biondi D; Greenberg SJ; Hulihan J;
    Clin Ther; 2009 Mar; 31(3):542-59. PubMed ID: 19393844
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Topiramate in Migraine Prevention: A 2016 Perspective.
    Silberstein SD
    Headache; 2017 Jan; 57(1):165-178. PubMed ID: 27902848
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparative Effectiveness of Combination Therapy with Statins and Angiotensin-Converting Enzyme Inhibitors versus Angiotensin II Receptor Blockers in Patients with Coronary Heart Disease: A Nationwide Population-Based Cohort Study in Korea.
    Lee J; Lee S
    Pharmacotherapy; 2018 Nov; 38(11):1095-1105. PubMed ID: 30225928
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.